Differentiated Thyroid Cancer in Navarra (Spain): Historic Cohort Results (1987–2003) | Zendy

María Pilar Salvador Egea | Zendy; Ana Aránzazu Echegoyen Silanes | Zendy; Eduardo Layana Echezuri | Zendy; Emma Anda Apiñariz | Zendy; Ana Puras Gil | Zendy; Edelmiro Menéndez Torre | Zendy; Lluís Forga Llenas | Zendy; Amaya Sainz de los Terreros | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Differentiated Thyroid Cancer in Navarra (Spain): Historic Cohort Results (1987–2003)

Author(s) -

María Pilar Salvador Egea,

Ana Aránzazu Echegoyen Silanes,

Eduardo Layana Echezuri,

Emma Anda Apiñariz,

Ana Puras Gil,

Edelmiro Menéndez Torre,

Lluís Forga Llenas,

Amaya Sainz de los Terreros

Publication year - 2011

Publication title -

isrn oncology

Language(s) - English

Resource type - Journals

eISSN - 2090-567X

pISSN - 2090-5661

DOI - 10.5402/2011/560503

Subject(s) - medicine , thyroid cancer , incidence (geometry) , lymph node , proportional hazards model , statistical significance , thyroid carcinoma , cohort , oncology , univariate , cancer , stage (stratigraphy) , thyroid , multivariate statistics , biology , statistics , mathematics , geometry , paleontology

. Navarra has the highest incidence of differentiated thyroid cancer in Spain. The aim of this study was to review its management carried out by the Navarra's multidisciplinary Thyroid Disease Unit, from 1987 to 2003. Material and Methods . 325 patients were studied to find the incidence, prevalence, and prognostic factors. Statistical analysis comprised univariate and multivariate Cox proportional hazards regression models for survival and tumor recurrence. Results . The average annual incidence was 3.6 per 100,000 inhabitants, with a final prevalence of 82.4 per 100,000. Regarding survival and recurrence, statistical significance was observed for stage IV, follicular carcinoma, capsular and prethyroid muscles invasion, and T4 group. Only survival was related to tumour size larger than 40 mm. Only recurrence was related to lymph node metastases and radioiodine dose higher than 100 mCi. Conclusions . Attendance of patients in a functional unit setting has allowed us to classify them into three risk groups.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research